Muscular Dystrophy Drug Price Jumps From $1,200 To $89,000 After FDA Approval
Health regulators have given their approval for the drug deflazacort for patients suffering from Duchenne muscular dystrophy. Available Overseas For $1,200 The steroid treatment has long been available outside United States but it was only last week that it received the green light from the U.S. Food and Drug Administration for Duchenne muscular dystrophy, a rare and incurable disease that most often affects boys and typically leads to […]